Pluri Inc. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-23: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0286813-defa14a_pluri.htm.
- 2020-05-20: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea122215-defa14a_pluristem.htm.
- 2019-04-26: Form DEFA14A; Description DEFA 14A; Document zk1922968.htm.
- 2018-04-03: Form DEFA14A; Description DEFA 14A; Document zk1821447.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-23 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0286813-defa14a_pluri.htm | |
| 2020-05-20 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea122215-defa14a_pluristem.htm | |
| 2019-04-26 | DEFA14A | DEFA 14A | zk1922968.htm | |
| 2018-04-03 | DEFA14A | DEFA 14A | zk1821447.htm | |
| 2017-03-30 | DEFA14A | DEFA14A | zk1719769.htm | |
| 2016-04-04 | DEFA14A | DEFA 14A | zk1618309.htm | |
| 2015-04-02 | DEFA14A | DEFA 14A | zk1516564.htm | |
| 2014-03-31 | DEFA14A | DEFA 14A | zk1414698.htm | |
| 2013-03-29 | DEFA14A | DEFA 14A | zk1312888.htm | |
| 2011-05-16 | DEFA14A | DEFA 14A | zk1109882.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |